Results 11 to 20 of about 23,672 (222)
The Journal of Clinical Endocrinology & Metabolism, 1997 This review presents a collection of uncommon aspects of acromegaly based on extensive experience of the authors.
COLAO, ANNAMARIA +3 more
openaire +5 more sources
Endocrinology and Metabolism Clinics of North America, 2001 Acromegaly is a slow developing disease caused by hypersecretion of growth hormone and insulin-like growth factor 1. Increased morbidity and mortality associated with the disease make early diagnosis and treatment crucial. This article reviews the etiology, clinical manifestations, and diagnosis of acromegaly, with an emphasis on newly available ...
Anat, Ben-Shlomo, Shlomo, Melmed
openaire +3 more sources
Anesthetic Management for Pituitary Tumor Resection in a Patient With Acromegalic Cardiomyopathy: A Case Report. [PDF]
Clin Case RepABSTRACT Acromegalic cardiomyopathy is one of the common comorbidities of cardiovascular diseases in patients with acromegaly, and it is also a major risk factor affecting the survival rate of patients with acromegaly. The perioperative management of such patients is a challenge for anesthesiologists.
Yang S, Wang M.
europepmc +2 more sources
Orphanet Journal of Rare Diseases, 2008 Acromegaly is an acquired disorder related to excessive production of growth hormone (GH) and characterized by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations. The prevalence is estimated at 1:140,000-250,000.
Chanson Philippe, Salenave Sylvie
openaire +4 more sources
Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan
Frontiers in Endocrinology, 2022 Acromegaly is a rare condition typically caused by benign pituitary adenomas, resulting in excessive production of growth hormone. Clinical manifestations of acromegaly are diverse, varying from the overgrowth of body tissue to cardiovascular, metabolic,
Marek Bolanowski +17 more
doaj +1 more source
Is H19 RNA a Useful Marker of Acromegaly and Its Complications? A Preliminary Study
Biomedicines, 2023 Acromegaly is a rare endocrine disorder caused by somatotroph pituitary adenoma. Besides its typical symptoms, it contributes to the development of cardiovascular, metabolic, and bone comorbidities. H19 RNA is a long non-coding RNA and it is suspected to
Małgorzata Rolla +4 more
doaj +1 more source
Increased Risk of Hip Fracture in Patients with Acromegaly: A Nationwide Cohort Study in Korea [PDF]
Endocrinology and Metabolism, 2023 Background Acromegaly leads to various skeletal complications, and fragility fractures are emerging as a new concern in patients with acromegaly. Therefore, this study investigated the risk of fractures in Korean patients with acromegaly. Methods We used
Jiwon Kim +7 more
doaj +1 more source
BMJ, 2007 Growth hormone (GH) is necessary for normal linear growth. Excess secretion of GH induces gigantism in prepubertal children and acromegaly in adults. Acromegaly arises from GH-secreting pituitary adenomas. Syndromes of excessive secretion of GH or acromegaly are caused 95 % of the time by a pituitary adenoma of the somatotrophs.
openaire +4 more sources
مجلة بغداد للعلوم, 2023 The purpose of this study was to measure serum levels of insulin-like growth factor-binding protein (IGFBP7), Insulin-like Growth Factor 1 (IGF-1), Growth Hormone (GH), Interleukin 6 (IL-6) and insulin in acromegaly patients and healthy controls.
Layla Othman Farhan +3 more
doaj +1 more source
CONDITION OF THE MUSCULOSKELETAL SYSTEM IN PATIENTSWITH ACROMEGALY.
Остеопороз и остеопатии, 2010 Despite the relatively low incidence of acromegaly (60-70 cases per I million inhabitants), this disease has a special place among the heterogeneous group of diseases that lead to the defeat of the locomotor apparatus.
A S Fedotova +7 more
doaj +1 more source